Oppenheimer Maintains Outperform on Bicycle Therapeutics, Maintains $48 Price Target
Oppenheimer Maintains Outperform on Bicycle Therapeutics, Maintains $48 Price Target
Oppenheimer保持對bicycle therapeutics的強勁推薦,並保持48美元的目標股價。
Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and maintains $48 price target.
Oppenheimer分析師Jay Olson維持Bicycle Therapeutics(納斯達克股票代碼:BCYC)的跑贏市場評級,目標價位維持48美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。